Atorvastatin, administered at the onset of reperfusion, and independent oflipid lowering, protects the myocardiumby up-regulating a pro-survival pathway
- 5 February 2003
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 41 (3) , 508-515
- https://doi.org/10.1016/s0735-1097(02)02816-4
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Nitric Oxide Mediates the Antiapoptotic Effect of Insulin in Myocardial Ischemia-ReperfusionCirculation, 2002
- 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition Prevents Endothelial NO Synthase Downregulation by Atherogenic Levels of Native LDLsArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Atorvastatin Upregulates Type III Nitric Oxide Synthase in Thrombocytes, Decreases Platelet Activation, and Protects From Cerebral Ischemia in Normocholesterolemic MiceStroke, 2000
- 14-3-3 Proteins and Survival Kinases Cooperate to Inactivate BAD by BH3 Domain PhosphorylationMolecular Cell, 2000
- Insulin Administered at Reoxygenation Exerts a Cardioprotective Effect in Myocytes by a Possible Anti-Apoptotic MechanismJournal of Molecular and Cellular Cardiology, 2000
- Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality?Heart, 2000
- Reperfusion Injury Revisited Is There a Role for Growth Factor Signaling in Limiting Lethal Reperfusion Injury?Trends in Cardiovascular Medicine, 1999
- Does reperfusion injury exist in humans?Journal of the American College of Cardiology, 1993
- Protection of Ischemia-Reperfusion Injury by Sydnonimine NO Donors via Inhibition of Neutrophil-Endothelium InteractionJournal of Cardiovascular Pharmacology, 1993
- A coronary primary prevention study of Scottish men aged 45?64 years: Trial designJournal of Clinical Epidemiology, 1992